Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$245M |
| 2 |
KeyCorp
KEY
|
+$199M |
| 3 |
RTX Corp
RTX
|
+$183M |
| 4 |
EMC
EMC CORPORATION
EMC
|
+$170M |
| 5 |
Ralph Lauren
RL
|
+$167M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$245M |
| 2 |
US Bancorp
USB
|
+$216M |
| 3 |
Apple
AAPL
|
+$207M |
| 4 |
Visa
V
|
+$188M |
| 5 |
Bank of America
BAC
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 44.36% |
| 2 | Financials | 9.66% |
| 3 | Consumer Discretionary | 8.08% |
| 4 | Energy | 7.72% |
| 5 | Technology | 6.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
HDY
6176
DELISTED
HYPERDYNAMICS CORP (NEW)
HDY
| $18K | ﹤0.01% |
4,003
+2,348
| +142% | +$10.4K |
2013 Q2
1 quarter
|
|
|
CHYR
6177
DELISTED
CHYRONHEGO CORP COM STK (NY)
CHYR
| $18K | ﹤0.01% |
+12,103
| New | +$18.9K |
2013 Q3
0 quarters
|
|
|
CTIC
6178
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $18K | ﹤0.01% |
+1,103
| New | +$12.8K |
2013 Q3
0 quarters
|
|
|
PGH
6179
PUT
DELISTED
Pengrowth Energy Corporation
PGH
| $18K | ﹤0.01% |
3,000
-12,600
| -81% | -$70.7K |
2013 Q2
1 quarter
|
|
|
PDLI
6180
PUT
DELISTED
PDL BioPharma, Inc.
PDLI
| $18K | ﹤0.01% |
2,200
-10,300
| -82% | -$82.8K |
2013 Q2
1 quarter
|
|
|
SSN
6181
DELISTED
Samson Oil & Gas Limited
SSN
| $18K | ﹤0.01% |
+3,721
| New | +$19K |
2013 Q3
0 quarters
|
|
|
SVA
6182
CALL
DELISTED
Sinovac Biotech, Ltd
SVA
| $18K | ﹤0.01% |
3,000
-300
| -9% | -$1.43K |
2013 Q2
1 quarter
|
|
|
CTLP
6183
DELISTED
Cantaloupe
CTLP
| $17K | ﹤0.01% |
+10,816
| New | +$21.1K |
2013 Q3
0 quarters
|
|
|
FOLD
6184
CALL
DELISTED
Amicus Therapeutics
FOLD
| $17K | ﹤0.01% |
7,500
+3,800
| +103% | +$9.54K |
2013 Q2
1 quarter
|
|
|
FOLD
6185
DELISTED
Amicus Therapeutics
FOLD
| $17K | ﹤0.01% |
7,436
-12,650
| -63% | -$31.7K |
2013 Q2
1 quarter
|
|
6186
Intellicheck
IDN
$46.4M
| $17K | ﹤0.01% |
+3,735
| New | +$16K |
2013 Q3
0 quarters
|
|
6187
CALL
Ironwood Pharmaceuticals
IRWD
$603M
| $17K | ﹤0.01% |
1,672
-15,522
| -90% | -$152K |
2013 Q2
1 quarter
|
|
|
TBHC
6188
PUT
DELISTED
The Brand House Collective
TBHC
| $17K | ﹤0.01% |
+900
| New | +$16.5K |
2013 Q3
0 quarters
|
|
6189
Rockwell Medical
RMTI
$35.1M
| $17K | ﹤0.01% |
14
-18
| -56% | -$12.2K |
2013 Q2
1 quarter
|
|
|
AAU
6190
DELISTED
Almaden Minerals Ltd
AAU
| $17K | ﹤0.01% |
+12,433
| New | +$20.2K |
2013 Q3
0 quarters
|
|
|
ONCT
6191
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $17K | ﹤0.01% |
6
-25
| -81% | -$124K |
2013 Q2
1 quarter
|
|
|
WWE
6192
PUT
DELISTED
World Wrestling Entertainment
WWE
| $17K | ﹤0.01% |
1,700
-100
| -6% | -$1.03K |
2013 Q2
1 quarter
|
|
|
EPAY
6193
PUT
DELISTED
Bottomline Technologies Inc
EPAY
| $17K | ﹤0.01% |
+600
| New | +$17.1K |
2013 Q3
0 quarters
|
|
|
XBKS
6194
DELISTED
Xenith Bankshares, Inc. Common Stock
XBKS
| $17K | ﹤0.01% |
+1,220
| New | +$19.7K |
2013 Q3
0 quarters
|
|
|
ELOS
6195
CALL
DELISTED
Syneron Medical Ltd
ELOS
| $17K | ﹤0.01% |
2,000
+1,400
| +233% | +$12.1K |
2013 Q2
1 quarter
|
|
|
MCGC
6196
PUT
DELISTED
MCG CAP CORP
MCGC
| $17K | ﹤0.01% |
3,300
-6,500
| -66% | -$33.5K |
2013 Q2
1 quarter
|
|
|
SVBL
6197
DELISTED
SILVER BULL RESOURCES, INC
SVBL
| $17K | ﹤0.01% |
48,360
+35,545
| +277% | +$13.2K |
2013 Q2
1 quarter
|
|
|
EDS
6198
DELISTED
EXCEED COMPANY LTD ORD SHS
EDS
| $17K | ﹤0.01% |
+11,233
| New | +$15.3K |
2013 Q3
0 quarters
|
|
|
IKAN
6199
DELISTED
IKANOS COMMUNICATIONS INC COM STK NEW (DE)
IKAN
| $17K | ﹤0.01% |
+1,336
| New | +$17.2K |
2013 Q3
0 quarters
|
|
|
PRIS
6200
DELISTED
PROMOTORA DE INFORMACIONES SA ADR REPSTG 4 CL A SHS
PRIS
| $17K | ﹤0.01% |
+10,009
| New | +$11.1K |
2013 Q3
0 quarters
|
|
Similar funds
Citadel Advisors's Q3 2013 Portfolio in Review
As of Q3 2013, Citadel Advisors held 7,215 positions worth $65.7B, up 13% from $58.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Citadel Advisors withdrew a net $4.68B in Q3 2013, closing 505 positions and reducing 3,074 holdings. Its most notable exit was NEWS CORPORATION CL-A, an estimated $166M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, up from 41% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Citadel Advisors opened a new position in ELAN CORP ADS(RP1 ORD4IRISH PN worth $100M.
- Citadel Advisors's largest Q3 2013 buy was ELAN CORP ADS(RP1 ORD4IRISH PN: 6,448,014 shares worth $100M.
- Citadel Advisors added most to Philip Morris in Q3 2013, an estimated $245M increase.
- Citadel Advisors's biggest Q3 2013 reduction was Pfizer, cutting an estimated $245M.
- Citadel Advisors fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $166M.
- Citadel Advisors's ten largest holdings make up 12% of its $65.7B portfolio in Q3 2013.
- Citadel Advisors opened 734 new positions and closed 505 in Q3 2013.
- Citadel Advisors's portfolio value rose 13% quarter-over-quarter to $65.7B.
Based on Citadel Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.